Published in Expert Opin Drug Deliv on January 06, 2013
Macrophages associated with tumors as potential targets and therapeutic intermediates. Nanomedicine (Lond) (2014) 0.89
Drug delivery, cell-based therapies, and tissue engineering approaches for spinal cord injury. J Control Release (2015) 0.85
Surface modification of microparticles causes differential uptake responses in normal and tumoral human breast epithelial cells. Sci Rep (2015) 0.82
The mixed lineage kinase-3 inhibitor URMC-099 improves therapeutic outcomes for long-acting antiretroviral therapy. Nanomedicine (2015) 0.81
Dendrimer, liposomes, carbon nanotubes and PLGA nanoparticles: one platform assessment of drug delivery potential. AAPS PharmSciTech (2014) 0.79
Drug Trafficking into Macrophages via the Endocytotic Receptor CD163. Membranes (Basel) (2015) 0.78
Development of mannose-anchored thiolated amphotericin B nanocarriers for treatment of visceral leishmaniasis. Nanomedicine (Lond) (2016) 0.75
Histone deacetylases in monocyte/macrophage development, activation and metabolism: refining HDAC targets for inflammatory and infectious diseases. Clin Transl Immunology (2016) 0.75
Active targeted drug delivery for microbes using nano-carriers. Curr Top Med Chem (2015) 0.75
Defect density in multiwalled carbon nanotubes influences ovalbumin adsorption and promotes macrophage activation and CD4(+) T-cell proliferation. Int J Nanomedicine (2016) 0.75
Nanomedicines for dysfunctional macrophage-associated diseases. J Control Release (2017) 0.75
Scavenger Receptor-Mediated Targeted Treatment of Collagen-Induced Arthritis by Dextran Sulfate-Methotrexate Prodrug. Theranostics (2017) 0.75
CD64: An Attractive Immunotherapeutic Target for M1-type Macrophage Mediated Chronic Inflammatory Diseases. Biomedicines (2017) 0.75
A review of ligand tethered surface engineered carbon nanotubes. Biomaterials (2013) 0.89
Carbohydrate-conjugated multiwalled carbon nanotubes: development and characterization. Nanomedicine (2009) 0.88
Macrophages targeting of amphotericin B through mannosylated multiwalled carbon nanotubes. J Drug Target (2012) 0.82
Receptor-based targeting of therapeutics. Ther Deliv (2013) 0.81
Development and characterization of dexamethasone mesylate anchored on multi walled carbon nanotubes. J Drug Target (2012) 0.81
Gemcitabine-loaded smart carbon nanotubes for effective targeting to cancer cells. J Drug Target (2013) 0.80
Dendrimer, liposomes, carbon nanotubes and PLGA nanoparticles: one platform assessment of drug delivery potential. AAPS PharmSciTech (2014) 0.79
Feed forward artificial neural network: tool for early detection of ovarian cancer. Sci Pharm (2011) 0.77
Topical delivery of enoxaparin using nanostructured lipid carrier. J Microencapsul (2013) 0.77
Hyperbranched dendritic nano-carriers for topical delivery of dithranol. J Drug Target (2013) 0.77
Fucosylated multiwalled carbon nanotubes for Kupffer cells targeting for the treatment of cytokine-induced liver damage. Pharm Res (2013) 0.76
Biomedical Applications of Carbon Nanotubes: A Critical Review. Curr Drug Deliv (2016) 0.76
Anti-Inflammatory and Antinociceptive Activities of a Hydroethanolic Extract of Tamarindus indica Leaves. Sci Pharm (2012) 0.76
Role of calcium alginate and mannitol in protecting Bifidobacterium. Appl Environ Microbiol (2012) 0.75
Nanotechnology in Drug Delivery: Safety and Toxicity Issues. Curr Pharm Des (2015) 0.75
Use of adsorbent and supercritical carbon dioxide to concentrate flavor compounds from orange oil. J Agric Food Chem (2002) 0.75